USA Transdermal Drug Delivery Systems Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Transdermal Drug Delivery Systems market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Transdermal Drug Delivery Systems market. Detailed analysis of key players, along with key growth strategies adopted by Transdermal Drug Delivery Systems industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Mentholatum Company

    • Laboratoires Genevrier

    • Teve(Actavis)

    • Nichiban

    • Sanofi

    • Bayer

    • Haw Par

    • Huarun 999

    • Endo

    • Hisamitsu

    • Novartis

    • UCB

    • Teikoku Seiyaku

    • Johnson & Johnson

    • Qizheng

    • Mylan

    • GSK

    • Lingrui

    By Type:

    • Fentanyl

    • Nitroglycerin

    • Estradiol

    • Nicotine

    • Other

    By End-User:

    • OTC

    • Rx

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transdermal Drug Delivery Systems Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Fentanyl from 2016 to 2027

      • 1.3.2 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Nitroglycerin from 2016 to 2027

      • 1.3.3 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Estradiol from 2016 to 2027

      • 1.3.4 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Nicotine from 2016 to 2027

      • 1.3.5 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of OTC from 2016 to 2027

      • 1.4.2 USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Rx from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Transdermal Drug Delivery Systems Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transdermal Drug Delivery Systems by Major Types

      • 3.4.1 Market Size and Growth Rate of Fentanyl

      • 3.4.2 Market Size and Growth Rate of Nitroglycerin

      • 3.4.3 Market Size and Growth Rate of Estradiol

      • 3.4.4 Market Size and Growth Rate of Nicotine

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Transdermal Drug Delivery Systems Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transdermal Drug Delivery Systems by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transdermal Drug Delivery Systems in OTC

      • 4.4.2 Market Size and Growth Rate of Transdermal Drug Delivery Systems in Rx

    5 Market Analysis by Regions

    • 5.1 USA Transdermal Drug Delivery Systems Production Analysis by Regions

    • 5.2 USA Transdermal Drug Delivery Systems Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Transdermal Drug Delivery Systems Landscape Analysis

    • 6.1 West USA Transdermal Drug Delivery Systems Landscape Analysis by Major Types

    • 6.2 West USA Transdermal Drug Delivery Systems Landscape Analysis by Major End-Users

    7 South USA Transdermal Drug Delivery Systems Landscape Analysis

    • 7.1 South USA Transdermal Drug Delivery Systems Landscape Analysis by Major Types

    • 7.2 South USA Transdermal Drug Delivery Systems Landscape Analysis by Major End-Users

    8 Middle West USA Transdermal Drug Delivery Systems Landscape Analysis

    • 8.1 Middle West USA Transdermal Drug Delivery Systems Landscape Analysis by Major Types

    • 8.2 Middle West USA Transdermal Drug Delivery Systems Landscape Analysis by Major End-Users

    9 Northeast USA Transdermal Drug Delivery Systems Landscape Analysis

    • 9.1 Northeast USA Transdermal Drug Delivery Systems Landscape Analysis by Major Types

    • 9.2 Northeast USA Transdermal Drug Delivery Systems Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Mentholatum Company

        • 10.1.1 Mentholatum Company Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Laboratoires Genevrier

        • 10.2.1 Laboratoires Genevrier Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Teve(Actavis)

        • 10.3.1 Teve(Actavis) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Nichiban

        • 10.4.1 Nichiban Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Sanofi

        • 10.5.1 Sanofi Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Bayer

        • 10.6.1 Bayer Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Haw Par

        • 10.7.1 Haw Par Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Huarun 999

        • 10.8.1 Huarun 999 Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Endo

        • 10.9.1 Endo Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Hisamitsu

        • 10.10.1 Hisamitsu Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Novartis

        • 10.11.1 Novartis Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 UCB

        • 10.12.1 UCB Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Teikoku Seiyaku

        • 10.13.1 Teikoku Seiyaku Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Johnson & Johnson

        • 10.14.1 Johnson & Johnson Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Qizheng

        • 10.15.1 Qizheng Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Mylan

        • 10.16.1 Mylan Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 GSK

        • 10.17.1 GSK Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Lingrui

        • 10.18.1 Lingrui Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Fentanyl from 2016 to 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Nitroglycerin from 2016 to 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Estradiol from 2016 to 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Nicotine from 2016 to 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of OTC from 2016 to 2027

    • Figure USA Transdermal Drug Delivery Systems Market Size and Growth Rate of Rx from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Transdermal Drug Delivery Systems Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Transdermal Drug Delivery Systems

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transdermal Drug Delivery Systems by Different Types from 2016 to 2027

    • Table Consumption Share of Transdermal Drug Delivery Systems by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Fentanyl

    • Figure Market Size and Growth Rate of Nitroglycerin

    • Figure Market Size and Growth Rate of Estradiol

    • Figure Market Size and Growth Rate of Nicotine

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Transdermal Drug Delivery Systems by Different End-Users from 2016 to 2027

    • Table Consumption Share of Transdermal Drug Delivery Systems by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of OTC

    • Figure Market Size and Growth Rate of Rx

    • Table USA Transdermal Drug Delivery Systems Production by Regions

    • Table USA Transdermal Drug Delivery Systems Production Share by Regions

    • Figure USA Transdermal Drug Delivery Systems Production Share by Regions in 2016

    • Figure USA Transdermal Drug Delivery Systems Production Share by Regions in 2021

    • Figure USA Transdermal Drug Delivery Systems Production Share by Regions in 2027

    • Table USA Transdermal Drug Delivery Systems Consumption by Regions

    • Table USA Transdermal Drug Delivery Systems Consumption Share by Regions

    • Figure USA Transdermal Drug Delivery Systems Consumption Share by Regions in 2016

    • Figure USA Transdermal Drug Delivery Systems Consumption Share by Regions in 2021

    • Figure USA Transdermal Drug Delivery Systems Consumption Share by Regions in 2027

    • Table West USA Transdermal Drug Delivery Systems Consumption by Types from 2016 to 2027

    • Table West USA Transdermal Drug Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2016

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2021

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2027

    • Table West USA Transdermal Drug Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table West USA Transdermal Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2016

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2021

    • Figure West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2027

    • Table South USA Transdermal Drug Delivery Systems Consumption by Types from 2016 to 2027

    • Table South USA Transdermal Drug Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by Types in 2016

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by Types in 2021

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by Types in 2027

    • Table South USA Transdermal Drug Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table South USA Transdermal Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2016

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2021

    • Figure South USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2027

    • Table Middle West USA Transdermal Drug Delivery Systems Consumption by Types from 2016 to 2027

    • Table Middle West USA Transdermal Drug Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2016

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2021

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by Types in 2027

    • Table Middle West USA Transdermal Drug Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Transdermal Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2016

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2021

    • Figure Middle West USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2027

    • Table Northeast USA Transdermal Drug Delivery Systems Consumption by Types from 2016 to 2027

    • Table Northeast USA Transdermal Drug Delivery Systems Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by Types in 2016

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by Types in 2021

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by Types in 2027

    • Table Northeast USA Transdermal Drug Delivery Systems Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Transdermal Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2016

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2021

    • Figure Northeast USA Transdermal Drug Delivery Systems Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Mentholatum Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mentholatum Company

    • Figure Sales and Growth Rate Analysis of Mentholatum Company

    • Figure Revenue and Market Share Analysis of Mentholatum Company

    • Table Product and Service Introduction of Mentholatum Company

    • Table Company Profile and Development Status of Laboratoires Genevrier

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Laboratoires Genevrier

    • Figure Sales and Growth Rate Analysis of Laboratoires Genevrier

    • Figure Revenue and Market Share Analysis of Laboratoires Genevrier

    • Table Product and Service Introduction of Laboratoires Genevrier

    • Table Company Profile and Development Status of Teve(Actavis)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teve(Actavis)

    • Figure Sales and Growth Rate Analysis of Teve(Actavis)

    • Figure Revenue and Market Share Analysis of Teve(Actavis)

    • Table Product and Service Introduction of Teve(Actavis)

    • Table Company Profile and Development Status of Nichiban

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nichiban

    • Figure Sales and Growth Rate Analysis of Nichiban

    • Figure Revenue and Market Share Analysis of Nichiban

    • Table Product and Service Introduction of Nichiban

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Haw Par

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Haw Par

    • Figure Sales and Growth Rate Analysis of Haw Par

    • Figure Revenue and Market Share Analysis of Haw Par

    • Table Product and Service Introduction of Haw Par

    • Table Company Profile and Development Status of Huarun 999

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Huarun 999

    • Figure Sales and Growth Rate Analysis of Huarun 999

    • Figure Revenue and Market Share Analysis of Huarun 999

    • Table Product and Service Introduction of Huarun 999

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Hisamitsu

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hisamitsu

    • Figure Sales and Growth Rate Analysis of Hisamitsu

    • Figure Revenue and Market Share Analysis of Hisamitsu

    • Table Product and Service Introduction of Hisamitsu

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Teikoku Seiyaku

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teikoku Seiyaku

    • Figure Sales and Growth Rate Analysis of Teikoku Seiyaku

    • Figure Revenue and Market Share Analysis of Teikoku Seiyaku

    • Table Product and Service Introduction of Teikoku Seiyaku

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Qizheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qizheng

    • Figure Sales and Growth Rate Analysis of Qizheng

    • Figure Revenue and Market Share Analysis of Qizheng

    • Table Product and Service Introduction of Qizheng

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Lingrui

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lingrui

    • Figure Sales and Growth Rate Analysis of Lingrui

    • Figure Revenue and Market Share Analysis of Lingrui

    • Table Product and Service Introduction of Lingrui


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.